Fatty acid synthase (FASN), a key enzyme of de novo lipid biosynthesis [5], is significantly unregulated in many cancers, including colorectal cancer (CRC) [6–8], and is associated with aggressive disease and a poor prognosis [9, 10]. Here, FASN is linked to cancer.